| Irbesartan - Wikipedia, the free encyclopedia Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names Aprovel, ... Read More |
| Generic for Aprovel (Irbesartan) 150Mg and 300Mg at International ... Generic for Aprovel 150Mg and 300Mg prescription medications are used for treating hypertension and are available at discounted rate only at International Drug Mart. Read More |
| Aprovel - Drugs.com Aprovel is a medicine available in a number of countries worldwide. A list of US medications equivalent to Aprovel is available on the Drugs.com website. Read More |
| Aprovel 150mg tablets - High blood pressure - eMC Medicines Guides Aprovel (Ap-roh-vel) is a medicine which is used in hypertension and treating kidney problems in people with diabetes. Aprovel contains irbesartan. Read More |
| Aprovel Side Effects Aprovel Side Effects - Complete Patient's Guide | User Reviews: Male patient, 61 years of age, weighting 216.1 |Aprovel 300mg|Aprovel Side Effect|Memory Loosing ... Read More |
| Aprovel 75 mg tablets, Aprovel 150 mg tablets, Aprovel 300 mg ... Summary of Product Characteristics for Aprovel 75 mg tablets, Aprovel 150 mg tablets, Aprovel 300 mg tablets. Detailed information for prescribers and healthcare ... Read More |
| Aprovel Aprovel tablets contain the active ingredient irbesartan, which is a type of medicine called an angiotensin II receptor antagonist. It works by preventing the action ... Read More |
| Aprovel - definition of Aprovel in the Medical dictionary - by the ... irbesartan /ir·be·sar·tan/ (ir″bĕ-sahr´tan) an angiotensin II receptor antagonist used as an antihypertensive. ir·be·sar·tan (r b-sär tn) Read More |
| Aprovel - European Drugs Reference Encyclopedia Aprovel, - European Drugs Reference Encyclopedia ... Summary for the public What is Aprovel? Aprovel is a medicine that contains the active substance irbesartan. Read More |
| European Medicines Agency - - Aprovel - EUROPA – EU website ... This is a summary of the European Public Assessment Report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies ... Read More |
